Literature DB >> 18708943

Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention.

Sarah H Lisanby1, Shirlene Sampson, Mustafa M Husain, Georgios Petrides, Rebecca G Knapp, W Vaughn McCall, Robert C Young, Joan Prudic, Charles H Kellner.   

Abstract

OBJECTIVES: Effective strategies to prolong remission after electroconvulsive therapy (ECT) are urgently needed. Fixed schedules for continuation ECT (C-ECT) cannot adapt to early signs of impending relapse. Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) is proposed as a novel patient-focused approach to individualize the ECT schedule. In STABLE, the ECT schedule adapts to symptom fluctuations to prevent overtreatment of those who do not need it and to recapture response in those who might have otherwise relapsed with a rigid dosing schedule. Here we back-test STABLE to optimize the algorithm for subsequent testing in a prospective trial.
METHODS: Three variations of the STABLE algorithm, differing in cutoff points to trigger or withhold additional ECT, were back-tested in a data set of 89 patients randomized to the C-ECT arm in the CORE (Consortium for Research on ECT) Study comparing C-ECT with combination pharmacotherapy.
RESULTS: The selected algorithm identified 100% of patients who ultimately relapsed as requiring additional ECT at an average of 2.2 weeks before relapse, while exposing 20% of sustained remitters to additional ECT. Other variations either failed to capture impending relapse or exposed an unacceptably large percentage of patients to potentially unnecessary ECT.
CONCLUSIONS: This patient-focused approach to relapse prevention is an attempt to provide the first operationalized guidance to the field regarding how to conduct C-ECT. The effectiveness of this approach should be tested in a randomized controlled trial.

Entities:  

Mesh:

Year:  2008        PMID: 18708943      PMCID: PMC2743247          DOI: 10.1097/YCT.0b013e318185fa6b

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  14 in total

Review 1.  Continuation and maintenance electroconvulsive therapy for the treatment of depressive illness: a response to the National Institute for Clinical Excellence report.

Authors:  Melissa Frederikse; Georgios Petrides; Charles Kellner
Journal:  J ECT       Date:  2006-03       Impact factor: 3.635

Review 2.  Continuation and maintenance ECT: a review of recent research.

Authors:  Chittaranjan Andrade; S Kurinji
Journal:  J ECT       Date:  2002-09       Impact factor: 3.635

3.  Antidepressant drug treatment in relation to the use of ECT.

Authors:  K Malcolm; J Dean; P Rowlands; M Peet
Journal:  J Psychopharmacol       Date:  1991-01       Impact factor: 4.153

4.  Resolution of SPECT-determined anterior cerebral hypoperfusion correlated with maintenance ECT-derived improvement in residual symptoms in a case of late-life psychotic depression.

Authors:  Kazumasa Suzuki; Shuichi Awata; Takehisa Takano; Yukio Ebina; Shinichi Numata; Atsushi Saito; Kae Ito; Hiroo Matsuoka
Journal:  Clin Nucl Med       Date:  2006-05       Impact factor: 7.794

5.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

Authors:  Charles H Kellner; Rebecca G Knapp; Georgios Petrides; Teresa A Rummans; Mustafa M Husain; Keith Rasmussen; Martina Mueller; Hilary J Bernstein; Kevin O'Connor; Glenn Smith; Melanie Biggs; Samuel H Bailine; Chitra Malur; Eunsil Yim; Shawn McClintock; Shirlene Sampson; Max Fink
Journal:  Arch Gen Psychiatry       Date:  2006-12

6.  Continuation ECT: relapse prevention in affective disorders.

Authors:  G Petrides; D Dhossche; M Fink; A Francis
Journal:  Convuls Ther       Date:  1994-09

7.  Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

Authors:  H A Sackeim; R F Haskett; B H Mulsant; M E Thase; J J Mann; H M Pettinati; R M Greenberg; R R Crowe; T B Cooper; J Prudic
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

8.  Resistance to antidepressant medications and short-term clinical response to ECT.

Authors:  J Prudic; R F Haskett; B Mulsant; K M Malone; H M Pettinati; S Stephens; R Greenberg; S L Rifas; H A Sackeim
Journal:  Am J Psychiatry       Date:  1996-08       Impact factor: 18.112

9.  The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.

Authors:  H A Sackeim; J Prudic; D P Devanand; P Decina; B Kerr; S Malitz
Journal:  J Clin Psychopharmacol       Date:  1990-04       Impact factor: 3.153

10.  Effectiveness of electroconvulsive therapy in community settings.

Authors:  Joan Prudic; Mark Olfson; Steven C Marcus; Rice B Fuller; Harold A Sackeim
Journal:  Biol Psychiatry       Date:  2004-02-01       Impact factor: 13.382

View more
  10 in total

1.  Relapse following successful electroconvulsive therapy for major depression: a meta-analysis.

Authors:  Ana Jelovac; Erik Kolshus; Declan M McLoughlin
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

Review 2.  Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature.

Authors:  Georgios Petrides; Kristen G Tobias; Charles H Kellner; Matthew V Rudorfer
Journal:  Neuropsychobiology       Date:  2011-07-29       Impact factor: 2.328

3.  Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital.

Authors:  Samuel T Wilkinson; Rachel B Katz; Mesut Toprak; Ryan Webler; Robert B Ostroff; Gerard Sanacora
Journal:  J Clin Psychiatry       Date:  2018-07-24       Impact factor: 4.384

4.  A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study.

Authors:  Charles H Kellner; Mustafa M Husain; Rebecca G Knapp; W Vaughn McCall; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shirlene Sampson; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Peter B Rosenquist; Ahmad Raza; Styliani Kaliora; Vassilios Latoussakis; Kristen G Tobias; Mimi C Briggs; Lauren S Liebman; Emma T Geduldig; Abeba A Teklehaimanot; Mary Dooley; Sarah H Lisanby
Journal:  Am J Psychiatry       Date:  2016-07-15       Impact factor: 18.112

Review 5.  A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression.

Authors:  Shawn M McClintock; Anna R Brandon; Mustafa M Husain; Robin B Jarrett
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

6.  Monitoring daily affective symptoms and memory function using interactive voice response in outpatients receiving electroconvulsive therapy.

Authors:  Tera L Fazzino; Terry Rabinowitz; Robert R Althoff; John E Helzer
Journal:  J ECT       Date:  2013-12       Impact factor: 3.635

7.  Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.

Authors:  W Vaughn McCall; Sarah H Lisanby; Peter B Rosenquist; Mary Dooley; Mustafa M Husain; Rebecca G Knapp; Georgios Petrides; Matthew V Rudorfer; Robert C Young; Shawn M McClintock; Martina Mueller; Joan Prudic; Robert M Greenberg; Richard D Weiner; Samuel H Bailine; Nagy A Youssef; Laryssa McCloud; Charles H Kellner
Journal:  J Psychiatr Res       Date:  2017-11-16       Impact factor: 4.791

8.  Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic.

Authors:  Simon Lambrichts; Kristof Vansteelandt; Bo Crauwels; Jasmien Obbels; Eva Pilato; Jonas Denduyver; Katrien Ernes; Pieter-Paul Maebe; Charlotte Migchels; Lore Roosen; Satya Buggenhout; Filip Bouckaert; Didier Schrijvers; Pascal Sienaert
Journal:  Acta Psychiatr Scand       Date:  2021-06-28       Impact factor: 7.734

9.  Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait.

Authors:  Pascal Sienaert; Simon Lambrichts; Leen Popleu; Elke Van Gerven; Satya Buggenhout; Filip Bouckaert
Journal:  Am J Geriatr Psychiatry       Date:  2020-04-22       Impact factor: 4.105

10.  Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.

Authors:  Sarah H Lisanby; Shawn M McClintock; William V McCall; Rebecca G Knapp; C Munro Cullum; Martina Mueller; Zhi-De Deng; Abeba A Teklehaimanot; Matthew V Rudorfer; Elisabeth Bernhardt; George Alexopoulos; Samuel H Bailine; Mimi C Briggs; Emma T Geduldig; Robert M Greenberg; Mustafa M Husain; Styliani Kaliora; Vassilios Latoussakis; Lauren S Liebman; Georgios Petrides; Joan Prudic; Peter B Rosenquist; Shirlene Sampson; Kristen G Tobias; Richard D Weiner; Robert C Young; Charles H Kellner
Journal:  Am J Geriatr Psychiatry       Date:  2021-05-17       Impact factor: 4.105

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.